Optimisation of cervical cancer screening programme by introducing genome detection of human papillomavirus using self-saving kits in women who do not participate in existing screening in the long term (Q66365): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in 2 languages: Changing unique label-description pair) |
(Removed claim: financed by (P890): Directorate-General for Regional and Urban Policy (Q8361), Removing unnecessary financed by statement) |
||
| Property / financed by | |||
| Property / financed by: Directorate-General for Regional and Urban Policy / rank | |||
Revision as of 01:09, 29 October 2020
Project Q66365 in Czech Republic
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Optimisation of cervical cancer screening programme by introducing genome detection of human papillomavirus using self-saving kits in women who do not participate in existing screening in the long term |
Project Q66365 in Czech Republic |
Statements
9,404,358.31 Czech koruna
0 references
12,124,877.76 Czech koruna
0 references
77.56 percent
0 references
1 March 2018
0 references
28 February 2021
0 references
Ústav zdravotnických informací a statistiky ČR
0 references
50°4'3.86"N, 14°25'18.62"E
0 references
12800
0 references
Předložený projekt směřuje k praktickému ověření zdravotnické technologie založené na vědeckých důkazech, která má reálný potenciál zvýšit efektivitu (diagnostickou bezpečnost, kvalitu, účinnost, nákladovou efektivitu) programu screeningu karcinomu děložního hrdla, který je v ČR bohužel stále nezanedbatelnou příčinou úmrtí na nádorové choroby. V případě úspěšného ověření lze očekávat zvýšení kvality programu a zvětšení jeho potenciálního dopadu na snížení úmrtnosti pro karcinom děložního hrdla. (Czech)
0 references
The submitted project is aimed at practical verification of medical technology based on scientific evidence, which has real potential to increase efficiency (diagnostic safety, quality, efficiency, cost-effectiveness) of cervical cancer screening programme, which is unfortunately still a significant cause of cancer death in the Czech Republic. In the event of successful verification, an increase in the quality of the programme and an increase in its potential impact on cervical cancer reduction may be expected. (English)
23 October 2020
0 references
Identifiers
CZ.03.2.63/0.0/0.0/15_039/0008171
0 references